Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Apr;32(1):186–191.

Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells.

G W Hunninghake, B F Haynes, J E Parrillo, A S Fauci
PMCID: PMC1541301  PMID: 668191

Abstract

The relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells has been studied. The peripheral blood contained a substantial proportion of monocytes (22 +/- 2.9%) compared to tonsil cell suspensions (2.5 +/- 0.3%). The percentages of T lymphocytes was significantly higher in the blood than in the tonsil (P is less than 0.01); however, the percentages of cells forming rosettes with 7S EA were not significantly different in each group (P greater than 0.5). Mitogen-induced cellular cytotoxicity by blood and tonsil mononuclear cells against Chang cells was proportional to the percentages of T lymphocytes in these cell suspensions, and both antibody-dependent and mitogen-induced cellular cytoxicity against sheep red blood cells was proportional to the percentages of monocytes in these suspensions. Tonsil mononuclear cell suspensions were incapable of mediating antibody-dependent cellular cytotoxicity against Chang cells, whereas blood mononuclear cells functioned normally. These findings are in contrast to the findings of similar percentages of Fc receptor-positive lymphocytes in blood and tonsil mononuclear cell suspensions. Previous studies have shown that the effector cells against antibody-coated Chang cells are Fc receptor-positive lymphocytes. These studies show that in the case of cytotoxicity mediated by an Fc receptor-bearing lymphoid cell, there may be a clear discrepancy between the relative proportions of Fc-bearing lymphoid cells in different organs and the relative levels of cytotoxicity.

Full text

PDF
186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brier A. M., Chess L., Schlossman S. F. Human antibody-dependent cellular cytotoxicity. Isolation and identification of a subpopulation of peripheral blood lymphocytes which kill antibody-coated autologous target cells. J Clin Invest. 1975 Dec;56(6):1580–1586. doi: 10.1172/JCI108240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cordier G., Samarut C., Brochier J., Revillard J. P. Antibody-dependent cell cytoxicity (ADCC). Characterization of 'killer' cells in human lymphoid organs. Scand J Immunol. 1976;5(3):233–242. doi: 10.1111/j.1365-3083.1976.tb00274.x. [DOI] [PubMed] [Google Scholar]
  3. Fauci A. S. Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. J Clin Invest. 1975 Jul;56(1):98–110. doi: 10.1172/JCI108085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fauci A. S., Pratt K. R. Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes. J Exp Med. 1976 Sep 1;144(3):674–684. doi: 10.1084/jem.144.3.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Holm G., Franksson C., Campbell A. C., Maclennan I. C. The cytotoxic activity of lymphocytes from human lymph in vitro. Clin Exp Immunol. 1974 Jul;17(3):361–369. [PMC free article] [PubMed] [Google Scholar]
  6. Holm G., Hammarström S. Haemolytic activity of human blood monocytes. Lysis of human erythrocytes treated with anti-A serum. Clin Exp Immunol. 1973 Jan;13(1):29–43. [PMC free article] [PubMed] [Google Scholar]
  7. Hunninghake G. W., Fauci A. S. Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. J Immunol. 1976 Jul;117(1):337–342. [PubMed] [Google Scholar]
  8. Hunninghake G. W., Fauci A. S. Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations. Cell Immunol. 1976 Sep;26(1):98–104. doi: 10.1016/0008-8749(76)90351-8. [DOI] [PubMed] [Google Scholar]
  9. Hunninghake G. W., Fauci A. S. Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes. Immunology. 1976 Jul;31(1):139–144. [PMC free article] [PubMed] [Google Scholar]
  10. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MacDonald H. R., Bonnard G. D., Sordat B., Zawodnik S. A. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. Scand J Immunol. 1975 Sep;4(5-6):487–497. doi: 10.1111/j.1365-3083.1975.tb02654.x. [DOI] [PubMed] [Google Scholar]
  12. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  13. MacLennan I. C., Harding B. The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. II. The mechanism of target cell damage by lymphoid cells from immunized rats. Immunology. 1970 Mar;18(3):405–412. [PMC free article] [PubMed] [Google Scholar]
  14. Nelson D. L., Bundy B. M., Pitchon H. E., Blaese R. M., Strober W. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1976 Nov;117(5 Pt 1):1472–1481. [PubMed] [Google Scholar]
  15. Nelson D. L., Bundy B. M., West T. D., Strober W. The nature of the effector cells mediating mitogen-induced cellular cytotoxicity (MICC) and antibody-dependent cellular cytotoxicity (ADCC). Cell Immunol. 1976 Apr;23(1):89–98. doi: 10.1016/0008-8749(76)90173-8. [DOI] [PubMed] [Google Scholar]
  16. O'Toole C., Saxon A., Bohrer R. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells. Clin Exp Immunol. 1977 Jan;27(1):165–171. [PMC free article] [PubMed] [Google Scholar]
  17. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  18. Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
  19. Rynnel-Dagö B., Möller E., Waterfield E. Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol. 1977 Mar;27(3):425–431. [PMC free article] [PubMed] [Google Scholar]
  20. Trinchieri G., De Marchi M., Mayr W., Savi M., Ceppellini R. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc. 1973 Dec;5(4):1631–1649. [PubMed] [Google Scholar]
  21. Zeijlemaker W. P., Roos M. T., Schellekens P. T., Eijsvoogel V. P. Antibody-dependent human lymphocytotoxicity: a micro assay system. Eur J Immunol. 1975 Aug;5(8):579–584. doi: 10.1002/eji.1830050815. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES